Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2022
19/7 12:34
Company Announcement Net sales of DARZALEX ® in the second quarter of 2022 totaled USD 1,986 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN , Denmark; July 19 , 20 2 2 – Genmab A/S ( Nasdaq: GMAB ) announced today that worldwide net trade...